![]() ![]() In this case, the "context" is the duration of a continuous infusion. ![]() Using concepts developed by Shafer and Varvel, these simulations are an attempt to provide context-sensitive half-times, as proposed by Hughes et al. The context-sensitive half-time simulations based on the NONMEM population parameters are perhaps the most clinically interpretable way of illustrating the pharmacokinetic differences between remifentanil and alfentanil. The optimal k e0is used to calculate the apparent effect-site concentrations and thus identify the "pseudosteady-state" concentration-effect relationship. The algorithm is thus an iterative process in which the hysteresis loops determined by numeric convolution of the measured drug concentrations with a potential k e0are successively "collapsed" until a k e0that results in minimal hysteresis is found. Potential k e0values are sequentially tested until the optimal estimate of k e0is obtained. The optimal k e0value minimizes the area of the hysteresis loop formed by plotting the apparent effect-site concentration versus effect. In summary, this k e0-estimating technique performs a numeric convolution of the measured drug concentrations with a candidate k e0value to calculate the apparent effect-site concentrations. The theoretical foundation of this technique is that, in the effect site, there should be no delay or hysteresis between changes in drug concentration and changes in pharmacologic effect. K e0was estimated using a hysteresis loop minimization technique. The aim of this study was to contrast the clinical pharmacology of remifentanil and alfentanil in healthy, adult male volunteers by constructing a detailed pharmacokinetic/pharmacodynamic model for each drug using an open-label, randomized, crossover study design. Preliminary evidence from volunteer and patient studies suggests that remifentanil may constitute the first true ultrashort-acting opioid for use as a supplement to general anesthesia. As an ester, remifentanil is susceptible to hydrolysis by blood and tissue nonspecific esterases, resulting in rapid metabolism to essentially inactive compounds. Although chemically related to the fentanyl family of short-acting 4-anilidopiperidine derivatives commonly used as supplements to general anesthesia, remifentanil is structurally unique among currently available opioids because of its ester linkages. ![]() REMIFENTANIL (hydrochloride salt of 3-1-piperidine]propanoic acid, methyl ester), formerly known as GI87084B, is a synthetic opioid that exhibits classic micro-agonist pharmacologic effects. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |